16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23345.05 (-0.46)

S&P 5960.5 (0.26)

LOGIN HERE

companylogoMeghmani Organics Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 543331 | NSE Symbol : MOL | ISIN : INE0CT101020 | Industry : Pesticides / Agrochemicals - Indian |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
30-Apr-2025 10-May-2025 Quarterly Results Quarterly Results & Audited Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 ,inter alia, to consider and approve audited Standalone and Consolidated Financial Results of the Company for the quarter & year ended on 31st March, 2025 along with Report of the Statutory Auditors thereon and any other business with the permission of the Chair Outcome of the Board Meeting held on May 10, 2025 AUDITED FINANCIAL RESULTS OF FY 2025. Appointment of M/s. Mukesh M. Shah & Co. (FRN:106625W), Chartered Accountants, Ahmedabad for a period of 5 years on expiry of tenure of 5 years of the existing Statutory Auditors. (As Per BSE Announcement Dated on 10.05.2025)
28-Jan-2025 08-Feb-2025 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve third quarter FY2025 financial results of the Company Outcome of the Board Meeting held on February 08, 2025 and submission of Financial results and Integrated Filing (Financial) - for the quarter ended on December 31, 2024 (As Per BSE Announcement Dated on 08/02/2025)
09-Oct-2024 26-Oct-2024 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2024 inter alia to consider and approve Meghmani Organics Limited informs that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 26th October 2024 inter alia to consider approve and take on record un-audited Financial Results for the quarter ended 30th September 2024 Outcome of Board Results (As Per BSE Announcement Dated on: 26/10/2024)
17-Jul-2024 27-Jul-2024 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2024 inter alia to consider and approve un-audited financial results (standalone and consolidated) for the quarter ended on 30.06.2024 Financial Results for the Quarter ended on 30.06.2024. Outcome of the Board Meeting held on July 27, 2024 and submission of unaudited Financial Results (Standalone and Consolidated) for the quarter ended on June 30, 2024 (As Per BSE Announcement dated on 27.07.2024)
22-Apr-2024 11-May-2024 Accounts Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2024 inter alia to consider and approve consideration and approval of Audited Financial Results for the year ended 31 March 2024 Outcome of the Board Meeting held on May 11, 2024 and submission of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended on March 31, 2024 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015. FINANCIAL RESULTS FOR F.Y. 2024. (As Per BSE Announcement Dated on 11/05/2024)
15-Jan-2024 30-Jan-2024 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve un-audited Financial Results for the quarter and Nine months ended 31st December 2023 Meghmani Organics Limited submits the unaudited financial results for the quarter and nine months ended on 31st December, 2023. Unaudited financial results for the quarter ended on 31st December, 2023. (As Per BSE Announcement dated on 30.01.2024)
16-Oct-2023 07-Nov-2023 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve unaudited financial results for the quarter ended on 30 September 2023 FINANCIAL RESULTS Q2 FY 2024 OUTCOME OF BOARD MEETING HELD ON 07.11.2023 RESIGNATION OF MR. SHALIN MEHTA AND APPOINTMENT OF MR. NIKUNT RAVAL. APPOINTMENT OF MR. NIKUNT RAVAL. (As Per BSE Announcement Dated on 07.11.2023)
02-Aug-2023 14-Aug-2023 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 14th August 2023 inter alia to consider approve and take on record the following; 1) Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June 2023 along with Limited Review Report of the Statutory Auditors thereon; and 2) Any other business with the permission of the Chair Outcome of the Board Meeting held on August 14, 2023 pursuant to regulation 30 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015 Meghmani Organics Limited submits the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30.06.2023. Meghmani Organics Limited submits the Change in Directors. (As Per BSE Announcement Dated on 14.08.2023)
20-Apr-2023 29-Apr-2023 Accounts Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2023 inter alia to consider and approve Intimation of Board Meeting for consideration of Audited Financial Results and recommendation of final Dividend for the year ended 31st March 2023 1. Outcome of the Board Meeting held on April 29, 2023 and submission of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended on March 31, 2023. 2. Recommended a final Dividend of Rs. 1.40 (140%) per equity share having face value of Rs. 1/- each for the financial year ended on March 31, 2023. Board Meeting held on April 29, 2023 and submission of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended on March 31, 2023. Board recommended a Final Dividend for FY 2022-23 (As per BSE Announcement Dated on 29/04/2023)
11-Jan-2023 21-Jan-2023 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2023 inter alia to consider and approve the un-audited Standalone and Consolidated Financial Results of the Company for the Quarter and nine months ended on 31 December 2022 along with the Limited Review Reports of the Statutory Auditors thereon. Outcome of the Board Meeting held on January 21, 2023 and submission of un-audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2022 pursuant to regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated on 21/01/2023)
11-Oct-2022 21-Oct-2022 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022 inter alia to consider and approve the un-audited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September 2022 along with the Limited Review Reports of the Statutory Auditors thereon. Outcome of the Board Meeting held on October 21, 2022 and submission of un-audited Financial Results (Standalone and Consolidated) for the Second quarter/half year ended on September 30, 2022 pursuant to regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015. (As per BSE Announcement Dated on 21/10/2022) Submission of Newspaper publication of Un-audited Financial Results (Standalone and Consolidated) for second quarter/half year ended September 30, 2022 (As Per BSE Announcement Dated on 22/10/2022)
07-Jul-2022 22-Jul-2022 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2022 inter alia to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 22 July 2022 inter alia to consider and approve the un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30 June 2022. Meghmani Organics Limited informs: (1) Un-audited Standalone and Consolidated Financial Results of the Company along with Limited Review Report issued by Statutory Auditors of the Company for the first quarter ended on June 30, 2022. The said Financial Results were reviewed and recommended by Audit Committee prior to placing the same before the Board. (2) Appointed Dr. Varesh Sinha (DIN: 03259880) and Mr. Shalin Mehta (DIN: 09679732) as a Non-Executive Independent Directors (Additional Director) for a term of five year w.e.f. July 22, 2022 which is subject to shareholders' approval. Meghmani Organics Limited informs: (1) Un-audited Standalone and Consolidated Financial Results of the Company along with Limited Review Report issued by Statutory Auditors of the Company for the first quarter ended on June 30, 2022. The said Financial Results were reviewed and recommended by Audit Committee prior to placing the same before the Board. (2) Appointed Dr. Varesh Sinha (DIN: 03259880) and Mr. Shalin Mehta (DIN: 09679732) as a Non-Executive Independent Directors (Additional Director) for a term of five year w.e.f. July 22, 2022 which is subject to shareholders'' approval. (As Per BSE Announcement Dated on 22.07.2022)
26-Apr-2022 02-May-2022 Quarterly Results Quarterly Results & Audited Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 ,inter alia, to consider and approve Pursuant to the requirement of Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, 2 May, 2022, inter alia to consider and approve the audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on 31 March, 2022. (As Per BSE Announcement Dated on 26.04.2022) Audited Results & Dividend & Quarterly Results (As Per Bulletin Dated on 27.04.2022) Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2022 ,inter alia, to consider and approve Board may consider and recommend Dividend at the Board Meeting to be held on Monday, 2nd May, 2022 for F.Y. 2021-22. (As Per BSE Announcement dated on 27.04.2022) Meghmani Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 02, 2022, inter alia, has recommended a final Dividend of Rs. 1.40 (140%) per equity share having face value of Rs. 1/- each for the financial year ended on March 31, 2022 subject to the approval of Shareholders in the ensuing Annual General Meeting which will be paid within statutory time limit after approval of Shareholders. Outcome of the Board Meeting held on May 2, 2022 and submission of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended on March ·31, 2022 pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. Meghmani Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 02, 2022, inter alia, has recommended a final Dividend of Rs. 1.40 (140%) per equity share having face value of Rs. 1/- each for the financial year ended on March 31, 2022 subject to the approval of Shareholders in the ensuing Annual General Meeting which will be paid within statutory time limit after approval of Shareholders. (As Per BSE Announcement Dated on 02.05.2022) Meghmani Organics Limited informs that Mr. CS Liew and Mr. Bhaskar Rao, Independent Directors of the Company have ceased to be Director on expiry of the term on 4th May, 2022. (As Per BSE Announcement Dated on 05.05.2022)
25-Jan-2022 02-Feb-2022 Quarterly Results Quarterly Results Outcome of the Board Meeting held on February 2, 2022 and submission of Un-Audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2021 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015. Outcome of the Board Meeting held on February 2, 2022 and submission of Un-Audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2021 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015 (As Per BSE Announcement Dated on 02.02.2022)
07-Oct-2021 26-Oct-2021 Quarterly Results Meghmani Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2021 ,inter alia, to consider and approve Meghmani informs that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 26th October, 2021, inter alia to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2021.Outcome of the Board Meeting held on October 26, 2021 and submission of Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2021 pursuant to regulation 33 of SEBl (Listing Obligations and Disclosure Requirements), Regulations, 2015(As per BSE Announcement Dated on 26/10/2021)Submission of Newspaper ;publication of Unaudited Financial Results (Standalone and Consolidated) for quarter and half year ended September 30, 2021(As Per BSE Announcement Dated on 28/10/2021)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +